Abatacept for the treatment of myositis-associated interstitial lung disease (ATtackMy-ILD)

By sjmartinez • April 25, 2025

Aggarwal R, Pongtarakulpanit N, Sullivan DI, Moghadam-Kia S, Bae SS, Wilkerson J, Saygin D, Marder G, Venuturupalli S, Dellaripa PF, Danoff SK, Doyle T, Hunninghake GM, Lee JS, Fischer A, Falk J, Johnson C, Koontz D, Ascherman DP, Oddis CV. Abatacept for the treatment of myositis-associated interstitial lung disease (ATtackMy-ILD). Rheumatology (Oxford). 2025 Apr 24:keaf218. doi: 10.1093/rheumatology/keaf218. Epub ahead of print. PMID: 40272902.

Tags: abatacept, anti-synthetase syndrome, Cedars Sinai DoM, Idiopathic inflammatory myopathy, interstitial lung disease, placebo-controlled trial, Publications, Pulmonary, Critical Care & Sleep Medicine, randomized, Rheumatology

Computational frameworks for enhanced extracellular vesicle biomarker discovery

Kim J, Yang JD, Agopian VG, Zhu Y, Tseng HR, You S. Computational frameworks for enhanced extracellular vesicle biomarker discovery. Exp Mol Med. 2026 Jan[...]

Minor Papillotomy for Treatment of Idiopathic Acute Pancreatitis With Pancreas Divisum: A Randomized Clinical Trial

Coté GA, Durkalski-Mauldin V, Fogel EL, Moffatt DC, Wang AY, Lara LF, Tarnasky PR, Buxbaum JL, Dai SC, Jonnalagadda S, Willingham FF, Ross A, Keswani[...]

Inverse association of insulin-like growth factor binding protein 1 with epicardial and intrathoracic adiposity in older adults: The Longenity study

Kankaria R, Charla JN, Ye K, Slipczuk L, Dey D, Levsky JM, Guzman W, Amadeo D, Zaidi A, Kizer JR, Barzilai N, Milman S, Bortnick[...]